نتایج جستجو برای: mmtt

تعداد نتایج: 42  

2016
FENG LIU Feng Liu

Aiming at the issue of moving multi-target tracking (MMTT) in double wireless video sensor network, this paper proposes a dynamic node cooperative program and a tracking forecasting association program. Particle multi-Bernoulli filtering algorithm is applied to perform the sensor cooperative scheme proposed, including cluster head node selecting scheme and cluster members selecting scheme. At e...

2014
Tihamer Orban Brian Bundy Dorothy J. Becker Linda A. DiMeglio Stephen E. Gitelman Robin Goland Peter A. Gottlieb Carla J. Greenbaum Jennifer B. Marks Roshanak Monzavi Antoinette Moran Mark Peakman Philip Raskin William E. Russell Desmond Schatz Diane K. Wherrett Darrell M. Wilson Jeffrey P. Krischer Jay S. Skyler

OBJECTIVE We previously reported that 2 years of costimulation modulation with abatacept slowed decline of β-cell function in recent-onset type 1 diabetes (T1D). Subsequently, abatacept was discontinued and subjects were followed to determine whether there was persistence of effect. RESEARCH DESIGN AND METHODS Of 112 subjects (ages 6-36 years) with T1D, 77 received abatacept and 35 received pla...

2017
Saba Sheikh Lalitha Gudipaty Diva D. De Leon Denis Hadjiliadis Christina Kubrak Nora K. Rosenfeld Sarah C. Nyirjesy Amy J. Peleckis Saloni Malik Darko Stefanovski Marina Cuchel Ronald C. Rubenstein Andrea Kelly Michael R. Rickels

Patients with pancreatic-insufficient cystic fibrosis (PI-CF) are at increased risk for developing diabetes. We determined β-cell secretory capacity and insulin secretory rates from glucose-potentiated arginine and mixed-meal tolerance tests (MMTTs), respectively, in pancreatic-sufficient cystic fibrosis (PS-CF), PI-CF, and normal control subjects, all with normal glucose tolerance, in order to...

Journal: :Diabetes 2015
Per-Ola Carlsson Erik Schwarcz Olle Korsgren Katarina Le Blanc

The retention of endogenous insulin secretion in type 1 diabetes is an attractive clinical goal, which opens possibilities for long-term restoration of glucose metabolism. Mesenchymal stromal cells (MSCs) constitute, based on animal studies, a promising interventional strategy for the disease. This prospective clinical study describes the translation of this cellular intervention strategy to pa...

2016
Ida Jakobsen Thomas P J Solomon Kristian Karstoft

Interval-type exercise is effective for improving glycemic control, but the optimal approach is unknown. The purpose of this study was to determine the importance of the interval length on changes in postprandial glycemic control following a single exercise bout. Twelve subjects with type 2 diabetes completed a cross-over study with three 1-hour interventions performed in a non-randomized but c...

2014
Mark D. Pescovitz Carla J. Greenbaum Brian Bundy Dorothy J. Becker Stephen E. Gitelman Robin Goland Peter A. Gottlieb Jennifer B. Marks Antoinette Moran Philip Raskin Henry Rodriguez Desmond A. Schatz Diane K. Wherrett Darrell M. Wilson Jeffrey P. Krischer Jay S. Skyler

OBJECTIVE We previously reported that selective depletion of B-lymphocytes with rituximab, an anti-CD20 monoclonal antibody, slowed decline of β-cell function in recent-onset type 1 diabetes mellitus (T1DM) at 1 year. Subjects were followed further to determine whether there was persistence of effect. RESEARCH DESIGN AND METHODS Eighty-seven subjects (aged 8-40 years) were randomly assigned t...

2014
Tara Ghazi Linda Rink Jennifer L. Sherr Kevan C. Herold

OBJECTIVE Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from the gastrointestinal tract. Treatment with GLP-1 analogs has proven to be of clinical use for patients with type 2 diabetes. Patients with type 1 diabetes, particularly those with residual β-cell function, may also respond to treatment, but the acute metabolic effects of GLP-1 analogs on these patients in rea...

2011
John M. Lachin Paula L. McGee Carla J. Greenbaum Jerry Palmer Mark D. Pescovitz Peter Gottlieb Jay Skyler

Preservation of β-cell function as measured by stimulated C-peptide has recently been accepted as a therapeutic target for subjects with newly diagnosed type 1 diabetes. In recently completed studies conducted by the Type 1 Diabetes Trial Network (TrialNet), repeated 2-hour Mixed Meal Tolerance Tests (MMTT) were obtained for up to 24 months from 156 subjects with up to 3 months duration of type...

2012
Carla J. Greenbaum

T ype 1 diabetes results from an immune assault on b-cells that progresses over time until the remaining b-cells are unable to keep up with demand and the ensuing hyperglycemia leads to clinical diagnosis. Many textbooks state that this occurs when 80% of the islets are destroyed; but in truth, the amount of residual insulin secretion at the time of clinical diagnosis is variable. The standard ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید